"Solving obesity greatly reduces [the] risk of other diseases, especially diabetes, and improves quality of life. We do need to find a way to make appetite inhibitors available to anyone who wants them," Sanders said on Tuesday, quoting the Tesla CEO from earlier this month. "And Mr. Musk is right." This statement emphasizes the critical importance of accessible treatments in addressing systemic health issues that affect millions.
Musk himself has waged a constant battle with the scale, having been fat-shamed by his very own father before opting to take Novo Nordisk's Wegovy to help slim down chemically. "I really am with Bernie on this one," Musk posted on Tuesday. This highlights his personal endorsement of affordable healthcare, bridging political divides with a shared solution.
Sanders was speaking at a subcommittee hearing that called Novo Nordisk CEO Lars Fruergaard Jørgensen as a witness. By the senator's estimate, Jørgensen is charging U.S. patients nine times what they charge German peers net of list price rebates. This statistic underscores the extensive markup in drug prices in the U.S., highlighting the dire need for reform.
74 cents of every dollar in sales goes to middlemen. This statistic points to the excessive costs baked into the healthcare system, showing how systemic inefficiencies contribute to unaffordable medication prices, prompting broad calls for change.
Collection
[
|
...
]